The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells

Yan Zhou(Shanghai Jiao Tong University), Peifeng Liu(Shanghai Jiao Tong University)
Scientific Reports
February 27, 2015
Cited by 25


Related Papers